480 related articles for article (PubMed ID: 17058779)
1. [Schizophrenia and cannabis consumption: epidemiology and clinical symptoms].
Jockers-Scherübl MC
Prax Kinderpsychol Kinderpsychiatr; 2006; 55(7):533-43. PubMed ID: 17058779
[TBL] [Abstract][Full Text] [Related]
2. Cannabis use and psychotic disorders: an update.
Hall W; Degenhardt L; Teesson M
Drug Alcohol Rev; 2004 Dec; 23(4):433-43. PubMed ID: 15763748
[TBL] [Abstract][Full Text] [Related]
3. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
Rubio G; Marín-Lozano J; Ferre F; Martínez-Gras I; Rodriguez-Jimenez R; Sanz J; Jimenez-Arriero MA; Carrasco JL; Lora D; Jurado R; López-Trabada JR; Palomo T
Compr Psychiatry; 2012 Nov; 53(8):1063-70. PubMed ID: 22682680
[TBL] [Abstract][Full Text] [Related]
4. Adequate antipsychotic treatment normalizes serum nerve growth factor concentrations in schizophrenia with and without cannabis or additional substance abuse.
Jockers-Scherübl MC; Rentzsch J; Danker-Hopfe H; Radzei N; Schürer F; Bahri S; Hellweg R
Neurosci Lett; 2006 Jun; 400(3):262-6. PubMed ID: 16540246
[TBL] [Abstract][Full Text] [Related]
5. Cannabis use and psychiatric and cogitive disorders: the chicken or the egg?
Di Forti M; Morrison PD; Butt A; Murray RM
Curr Opin Psychiatry; 2007 May; 20(3):228-34. PubMed ID: 17415074
[TBL] [Abstract][Full Text] [Related]
6. Brain-derived neurotrophic factor serum concentrations are increased in drug-naive schizophrenic patients with chronic cannabis abuse and multiple substance abuse.
Jockers-Scherübl MC; Danker-Hopfe H; Mahlberg R; Selig F; Rentzsch J; Schürer F; Lang UE; Hellweg R
Neurosci Lett; 2004 Nov; 371(1):79-83. PubMed ID: 15500971
[TBL] [Abstract][Full Text] [Related]
7. [Cannabis and Schizophrenia: new findings in an old debate].
Kawohl W; Rössler W
Neuropsychiatr; 2008; 22(4):223-9. PubMed ID: 19080993
[TBL] [Abstract][Full Text] [Related]
8. [Do alcohol or drug abuse induce schizophrenia?].
Hambrecht M; Häfner H
Nervenarzt; 1996 Jan; 67(1):36-45. PubMed ID: 8676987
[TBL] [Abstract][Full Text] [Related]
9. Familial predisposition for psychiatric disorder: comparison of subjects treated for cannabis-induced psychosis and schizophrenia.
Arendt M; Mortensen PB; Rosenberg R; Pedersen CB; Waltoft BL
Arch Gen Psychiatry; 2008 Nov; 65(11):1269-74. PubMed ID: 18981338
[TBL] [Abstract][Full Text] [Related]
10. Implicit and explicit affective associations towards cannabis use in patients with recent-onset schizophrenia and healthy controls.
Dekker N; Smeerdijk AM; Wiers RW; Duits JH; van Gelder G; Houben K; Schippers G; Linszen DH; de Haan L
Psychol Med; 2010 Aug; 40(8):1325-36. PubMed ID: 19917142
[TBL] [Abstract][Full Text] [Related]
11. Chronic cannabis abuse raises nerve growth factor serum concentrations in drug-naive schizophrenic patients.
Jockers-Scherübl MC; Matthies U; Danker-Hopfe H; Lang UE; Mahlberg R; Hellweg R
J Psychopharmacol; 2003 Dec; 17(4):439-45. PubMed ID: 14870957
[TBL] [Abstract][Full Text] [Related]
12. Illicit substance use and its correlates in first episode psychosis.
Mazzoncini R; Donoghue K; Hart J; Morgan C; Doody GA; Dazzan P; Jones PB; Morgan K; Murray RM; Fearon P
Acta Psychiatr Scand; 2010 May; 121(5):351-8. PubMed ID: 19824986
[TBL] [Abstract][Full Text] [Related]
13. Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes.
Bersani G; Orlandi V; Kotzalidis GD; Pancheri P
Eur Arch Psychiatry Clin Neurosci; 2002 Apr; 252(2):86-92. PubMed ID: 12111342
[TBL] [Abstract][Full Text] [Related]
14. [Impact of cannabis consumption on brain development and the risk of developing psychotic disorders].
Gudlowski Y; Lautenschlager M
Gesundheitswesen; 2008 Nov; 70(11):653-7. PubMed ID: 19039723
[TBL] [Abstract][Full Text] [Related]
15. The neuropsychology of cannabis and other substance use in schizophrenia: review of the literature and critical evaluation of methodological issues.
Coulston CM; Perdices M; Tennant CC
Aust N Z J Psychiatry; 2007 Nov; 41(11):869-84. PubMed ID: 17924240
[TBL] [Abstract][Full Text] [Related]
16. [Cognitive and psychotic effects after cessation of chronic cannabis use].
van Amsterdam JG; van der Laan JW; Slangen JL
Ned Tijdschr Geneeskd; 1998 Mar; 142(10):504-8. PubMed ID: 9623095
[TBL] [Abstract][Full Text] [Related]
17. Substance use and cognition in early psychosis.
Pencer A; Addington J
J Psychiatry Neurosci; 2003 Jan; 28(1):48-54. PubMed ID: 12587850
[TBL] [Abstract][Full Text] [Related]
18. Delusions incorporating cannabis use in dually diagnosed patients with a primary psychotic disorder.
Flanders SE
Aust N Z J Psychiatry; 2007 Nov; 41(11):934-6. PubMed ID: 17924247
[TBL] [Abstract][Full Text] [Related]
19. [Is cannabis a vulnerability factor in schizophrenic disorders].
Laqueille X
Arch Pediatr; 2009 Sep; 16(9):1302-5. PubMed ID: 19640690
[TBL] [Abstract][Full Text] [Related]
20. A comparison of symptoms and family history in schizophrenia with and without prior cannabis use: implications for the concept of cannabis psychosis.
Boydell J; Dean K; Dutta R; Giouroukou E; Fearon P; Murray R
Schizophr Res; 2007 Jul; 93(1-3):203-10. PubMed ID: 17462864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
